1. Home
  2. WYHG vs MGNX Comparison

WYHG vs MGNX Comparison

Compare WYHG & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WYHG
  • MGNX
  • Stock Information
  • Founded
  • WYHG 1915
  • MGNX 2000
  • Country
  • WYHG China
  • MGNX United States
  • Employees
  • WYHG N/A
  • MGNX N/A
  • Industry
  • WYHG
  • MGNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WYHG
  • MGNX Health Care
  • Exchange
  • WYHG NYSE
  • MGNX Nasdaq
  • Market Cap
  • WYHG 77.0M
  • MGNX 87.7M
  • IPO Year
  • WYHG 2024
  • MGNX 2013
  • Fundamental
  • Price
  • WYHG $1.25
  • MGNX $1.61
  • Analyst Decision
  • WYHG
  • MGNX Hold
  • Analyst Count
  • WYHG 0
  • MGNX 9
  • Target Price
  • WYHG N/A
  • MGNX $5.33
  • AVG Volume (30 Days)
  • WYHG 208.4K
  • MGNX 1.3M
  • Earning Date
  • WYHG 08-15-2025
  • MGNX 08-05-2025
  • Dividend Yield
  • WYHG N/A
  • MGNX N/A
  • EPS Growth
  • WYHG N/A
  • MGNX N/A
  • EPS
  • WYHG 0.20
  • MGNX N/A
  • Revenue
  • WYHG $147,996,867.00
  • MGNX $154,050,000.00
  • Revenue This Year
  • WYHG N/A
  • MGNX N/A
  • Revenue Next Year
  • WYHG N/A
  • MGNX N/A
  • P/E Ratio
  • WYHG $4.84
  • MGNX N/A
  • Revenue Growth
  • WYHG 19.02
  • MGNX 255.31
  • 52 Week Low
  • WYHG $1.10
  • MGNX $0.99
  • 52 Week High
  • WYHG $12.00
  • MGNX $5.77
  • Technical
  • Relative Strength Index (RSI)
  • WYHG N/A
  • MGNX 59.02
  • Support Level
  • WYHG N/A
  • MGNX $1.34
  • Resistance Level
  • WYHG N/A
  • MGNX $1.65
  • Average True Range (ATR)
  • WYHG 0.00
  • MGNX 0.11
  • MACD
  • WYHG 0.00
  • MGNX 0.04
  • Stochastic Oscillator
  • WYHG 0.00
  • MGNX 91.40

About WYHG WING YIP FOOD HOLDINGS GROUP LTD SPON ADS EACH REP 1 ORD

Wing Yip Food Holdings Group Ltd is a meat producer. The main categories of products are cured meat products, including cured pork sausages, cured pork meat and other cured meat products, such as cured chicken, cured duck and cured fish; snack products, including ready-to-eat sausages, jerky, duck necks, duck feet and claypot rice; and frozen meat products, including frozen sausages, frozen beef patties and frozen chicken breast fillets.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: